{"rows":[{"id":5338,"title":"Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans","authors":"Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson","journal":"PLoS ONE","publication_date":"2010-12-01","publication_year":2010,"doi":"10.1371/journal.pone.0014074","pubmed_id":"21152030","openalex_id":"https://openalex.org/W2001007038","source_url":"https://doi.org/10.1371/journal.pone.0014074","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Randomized Controlled Trial,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:05","last_checked":"2026-07-04 06:52:05","bibtex":null,"source_record_id":"PMID:21152030","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1371/journal.pone.0014074","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:21152030","source_url":"https://doi.org/10.1371/journal.pone.0014074","doi":"10.1371/journal.pone.0014074","pmid":"21152030","publication_date":"2010-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4747,"title":"Extended difficulties following the use of psychedelic drugs: A mixed methods study","authors":"Jules Evans, Oliver Robinson, Eirini K. Argyri, Shayam Suseelan, Ashleigh Murphy-Beiner, Rosalind McAlpine, David Luke, Katrina Michelle, Ed Prideaux","journal":"PLoS ONE","publication_date":"2023-10-23","publication_year":2023,"doi":"10.1371/journal.pone.0293349","pubmed_id":"37874826","openalex_id":"https://openalex.org/W4387902564","source_url":"https://doi.org/10.1371/journal.pone.0293349","substance_tags":"psilocybin","topic_tags":"Anxiety,Receptor Pharmacology,Emotional Processing,Safety","study_type":"Qualitative Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-07-04 06:34:45","bibtex":null,"source_record_id":"PMID:37874826","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1371/journal.pone.0293349","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:37874826","source_url":"https://doi.org/10.1371/journal.pone.0293349","doi":"10.1371/journal.pone.0293349","pmid":"37874826","publication_date":"2023-10-23","importer_version":"2.1.3","text_redistributed":false}}],"total":2,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"PLoS ONE","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}